For sales

📢Highlights from the Week of 25th August 2025 to 1st September 2025 in the world of pharma and healthcare! 🗞️👀

Vyuhpharma Highlights from the Week of 25th August 2025 to 1st Septmeber 2025 Eisai, Biogen (FDA, Approval) FDA approved LEQEMBI IQLIK for weekly at-home maintenance in early Alzheimer's ahead of October 2025 launch Amgen (FDA, Approval) FDA expanded the approval for REPATHAl to include adults at risk of cardiovascular events from uncontrolled LDL-C without prior heart disease Sanofi (FDA, Approval) Sanofi's WAYRILZ becomes the first FDA-approved BTK inhibitor for persistent or chronic ITP after LUNA 3 success Pfizer, BioNTech (FDA, Approval) Pfizer and BioNTech's COMIRNATY LP.8.1 has been approved by the FDA for adults aged 65 and older, as well as high-risk individuals aged 5 to 64, to prevent severe COVID-19 All logos and trademarks remain the intellectual properties of their respective owners
Download

Connect with us

Please fill in the information below, and we'll get back to you.